These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18980212)

  • 1. Stem cells in development of therapeutics for Parkinson's disease: a perspective.
    Xi J; Zhang SC
    J Cell Biochem; 2008 Dec; 105(5):1153-60. PubMed ID: 18980212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic Trk and G Protein Signalings Regulate Dopaminergic Neurodifferentiation in Human Trophoblast Stem Cells.
    Tsai EM; Wang YC; Lee TT; Tsai CF; Chen HS; Lai FJ; Yokoyama KK; Hsieh TH; Wu RM; Lee JN
    PLoS One; 2015; 10(11):e0143852. PubMed ID: 26606046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human amniotic fluid stem cells do not differentiate into dopamine neurons in vitro or after transplantation in vivo.
    Donaldson AE; Cai J; Yang M; Iacovitti L
    Stem Cells Dev; 2009 Sep; 18(7):1003-12. PubMed ID: 19049321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.
    Kim JH; Auerbach JM; Rodríguez-Gómez JA; Velasco I; Gavin D; Lumelsky N; Lee SH; Nguyen J; Sánchez-Pernaute R; Bankiewicz K; McKay R
    Nature; 2002 Jul; 418(6893):50-6. PubMed ID: 12077607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient induction of dopaminergic neurons from embryonic stem cells for application to Parkinson's disease.
    Kim DW
    Yonsei Med J; 2004 Jun; 45 Suppl():23-7. PubMed ID: 15250046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models of repair mechanisms for future treatment modalities of Parkinson's disease.
    Isacson O
    Brain Res Bull; 2002 Apr; 57(6):839-46. PubMed ID: 12031282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cells may reshape the prospect of Parkinson's disease therapy.
    Sonntag KC; Simantov R; Isacson O
    Brain Res Mol Brain Res; 2005 Mar; 134(1):34-51. PubMed ID: 15790528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival.
    Lee HS; Bae EJ; Yi SH; Shim JW; Jo AY; Kang JS; Yoon EH; Rhee YH; Park CH; Koh HC; Kim HJ; Choi HS; Han JW; Lee YS; Kim J; Li JY; Brundin P; Lee SH
    Stem Cells; 2010 Mar; 28(3):501-12. PubMed ID: 20049900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease.
    Parish CL; Parisi S; Persico MG; Arenas E; Minchiotti G
    Stem Cells; 2005 Apr; 23(4):471-6. PubMed ID: 15790767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats.
    Ben-Hur T; Idelson M; Khaner H; Pera M; Reinhartz E; Itzik A; Reubinoff BE
    Stem Cells; 2004; 22(7):1246-55. PubMed ID: 15579643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.
    Arenas E
    Ann N Y Acad Sci; 2005 May; 1049():51-66. PubMed ID: 15965107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed differentiation into neural lineages and therapeutic potential of porcine embryonic stem cells in rat Parkinson's disease model.
    Yang JR; Liao CH; Pang CY; Huang LL; Lin YT; Chen YL; Shiue YL; Chen LR
    Cell Reprogram; 2010 Aug; 12(4):447-61. PubMed ID: 20698783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells and neuroregeneration in Parkinson's disease.
    Glavaski-Joksimovic A; Bohn MC
    Exp Neurol; 2013 Sep; 247():25-38. PubMed ID: 23542820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The colayer method as an efficient way to genetically modify mesencephalic progenitor cells transplanted into 6-OHDA rat model of Parkinson's disease.
    Ratzka A; Kalve I; Özer M; Nobre A; Wesemann M; Jungnickel J; Köster-Patzlaff C; Baron O; Grothe C
    Cell Transplant; 2012; 21(4):749-62. PubMed ID: 21929871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current state of stem cell research for the treatment of Parkinson's disease.
    Gerlach M; Braak H; Hartmann A; Jost WH; Odin P; Priller J; Schwarz J
    J Neurol; 2002 Oct; 249 Suppl 3():III/33-5. PubMed ID: 12522570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of cell-based transplantation therapies for neurodegenerative disorders.
    Lazic SE; Barker RA
    J Hematother Stem Cell Res; 2003 Dec; 12(6):635-42. PubMed ID: 14977473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease.
    Arenas E
    J Mol Cell Biol; 2014 Feb; 6(1):42-53. PubMed ID: 24431302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell therapy for Parkinson's disease: problems and prospects.
    Björklund A
    Novartis Found Symp; 2005; 265():174-86; discussion 187, 204-211. PubMed ID: 16050257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial stem cell transplantation restores dopamine production in a Parkinson's disease model.
    Wolff EF; Gao XB; Yao KV; Andrews ZB; Du H; Elsworth JD; Taylor HS
    J Cell Mol Med; 2011 Apr; 15(4):747-55. PubMed ID: 20406327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.